Dexcom | DXCM - مصاريف البيع والإدارة

سعر السهم
61.57
التغيير اليومي
-1.13 -1.80%
شهريا
-7.88%
سنويا
-14.08%
Q2 التوقعات
60.25




مصاريف البيع والإدارة تغيير تاريخ
Abbott USD 3.27B 138M 2026-03
Align Technology USD 441.68M 23.88M 2025-12
AtriCure USD 78.34M 109K 2025-12
Avanos Medical USD 78.8M 1.2M 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Globus Medical USD 318.48M 4.88M 2025-12
Inogen USD 43.77M 510K 2024-06
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
J&J USD 6.03B 719M 2026-03
Masimo USD 128M 11.6M 2025-12
Medtronic 2.97B 159M 2025-09
Merit Medical Systems USD 114.83M 7.45M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Solventum Corp USD 759M 15M 2025-12
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
West Pharmaceutical Services USD 99.5M 7M 2026-03
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12